List of Clinical Studies

Statin Intolerance: A Randomized, double-blind, placebo-controlled study to assess the effects of bempedoic acid (etc-1002) on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin intolerant. Hypothesis is that bempedoic acid, compared with placebo, will reduce the risk of CV events in patients with, or at high risk for, CVD who are statin intolerant
Read more.

Angel Mulkay, MD

Overweight or obesity: SELECT - Semaglutide effects on cardiovascular outcomes in people with overweight or obesity. Hypothesis is that of CV risk reduction for semaglutide once-weekly versus placebo both added to standard of care in subjects with established CV disease and overweight or obesity and without diabetes.
Read more.

Thomas Birch, MD

Heart Failure: Care optimization through patient and hospital engagement clinical trial for heart failure—CONNECT-HF.
Read more.

Angel Mulkay, MD

Myocardial Infarction: Study of Access Site for Enhancing PCI in STEMI for seniors (SAFE-STEMI for seniors)
Read more.

Angel Mulkay, MD

Myocardial Infarction: A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
Read more.

Angel Mulkay, MD

Myocardial Infarction: Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Acute Coronary Syndrome (UPSTREAM): An ED Based Clinical Registry
Read more.

Angel Mulkay, MD

We are open.
We are clean.
We are ready.

Medical Care

Cancer Care

Specialty Services

Medical Care & Treatments

Patients & Visitors

For Patients

For Visitors

Directions & Parking

Amenities & Services

Community Health

About Holy Name Medical Center

Quick Links

Key Phone Numbers

Medical Center Operator

Physician Referral Service

Patient Information

Foundation (Donations)

Human Resources

Medical Staff Office

In This Section

For More Information:

List of Clinical Studies


Cardiology

Study Name	Principal Investigator

Statin Intolerance: A Randomized, double-blind, placebo-controlled study to assess the effects of bempedoic acid (etc-1002) on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin intolerant. Hypothesis is that bempedoic acid, compared with placebo, will reduce the risk of CV events in patients with, or at high risk for, CVD who are statin intolerant Read more.	Angel Mulkay, MD

Overweight or obesity: SELECT - Semaglutide effects on cardiovascular outcomes in people with overweight or obesity. Hypothesis is that of CV risk reduction for semaglutide once-weekly versus placebo both added to standard of care in subjects with established CV disease and overweight or obesity and without diabetes. Read more.	Thomas Birch, MD

Heart Failure: Care optimization through patient and hospital engagement clinical trial for heart failure—CONNECT-HF. Read more.	Angel Mulkay, MD

Myocardial Infarction: Study of Access Site for Enhancing PCI in STEMI for seniors (SAFE-STEMI for seniors) Read more.	Angel Mulkay, MD

Myocardial Infarction: A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome Read more.	Angel Mulkay, MD

Myocardial Infarction: Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Acute Coronary Syndrome (UPSTREAM): An ED Based Clinical Registry Read more.	Angel Mulkay, MD

We are open.We are clean.We are ready.

Medical Care

Cancer Care

Specialty Services

Medical Care & Treatments

Patients & Visitors

For Patients

For Visitors

Directions & Parking

Amenities & Services

Community Health

About Holy Name Medical Center

Quick Links

Key Phone Numbers

Medical Center Operator

Physician Referral Service

Patient Information

Foundation (Donations)

Human Resources

Medical Staff Office

List of Clinical Studies

In This Section

For More Information:

List of Clinical Studies

We are open.
We are clean.
We are ready.